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Summary Incidence rates of bacteraemia and catheter-related infections
were measured prospectively amongst haematological patients having long-term
catheters and hospitalised in the ambulatory care unit between November 2005
and October 2006. The following risk factors were collected: age, sex, catheter
type, follow-up duration, level of personal hygiene, pathology, number of lines of
treatment, autograft and erythropoietin treatment.
340 patients were included, having 353 catheters (100 of the Groshong-type,
followed during 17,621 days, and 253 of the type with implantable ports, fol-
lowed during 51,049 days). 0.13 catheter-related infections and 0.07 bacteraemia
per 100 catheter days were observed with the Groshong-type catheter, whereas
0.05 (P < 10−5) catheter-related infections and 0.05 (P = 0.048) bacteraemia were
observed amongst patients with implantable ports. A multivariate analysis (Cox
method taking into account the length of follow-up) on risk factors highlighted a
signiﬁcant effect of the type of catheter on catheter-related infections (Groshong
versus implantable port OR = 5.74, P < 10−3), and of several factors on bacteraemia
(lymphoma versus other pathologies OR = 3.19, P = 0.041; erythropoietin treatment
OR = 2.88, P = 0.009; autograft OR = 3.35, P = 0.011; number of lines of treatment
OR= 0.68, P = 0.047). It was not possible to determine if poor levels of personal
hygiene had a signiﬁcant impact, due to large numbers of missing data. These results,
consistent with other studies, are not only useful in validating prevention policy but
also in demonstrating lack of catheter traceability.
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he most common infections in haematological
atients are bacteraemia and catheter-related
nfections. These infections, which could result in
atheter removal or compromise ongoing treat-
ent, can give rise to signiﬁcantly increased
Sciences. Published by Elsevier Ltd. All rights reserved.
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ortality risk amongst affected patients. It is
herefore important to identify frequency and risk
actors in order to promote suitable prevention
easures. The epidemiology of these infections has
ften been studied [1—7], but usually for hospi-
alised patients, followed in conventional units, or
or paediatrics patients. So, few studies on ambula-
ory patients exist [8—11], in spite of the increasing
umbers of haematological ambulatory patients.
Overall, published studies have shown a lower
ate of infection with implantable ports, coherent
ith the increasing use of this mode of central
enous access, which furthermore allows a bet-
er quality of life for the patient [12,13]. This
tudy was performed to determine the frequency
f infections occurring amongst haematological
mbulatory patients, with Groshong-type catheters
r ones with totally implantable ports, during a
ne year follow-up period, in order to assess the
requency and to evaluate both opportunity and
easibility of survey in a given population. No
istinction was made between hospital-acquired
nfections or infections acquired outside the hos-
ital, due to the lack of means to make this
istinction.
ethod
bjective: Measurement of bacteraemia and cen-
ral venous catheter infection incidence rates and
umulative incidence rates on ambulatory patients
ith long-term catheters during a one year follow-
p period: All patients with central catheters,
ospitalised at the haematological ambulatory
are unit of the Centre Hospitalier Lyon Sud
France) between the 1st of November 2005 and
he 31st of October 2006 were included prospec-
ively. Patients were identiﬁed and followed during
heir stay. The catheters in use in the service were
hose with implantable ports from different manu-
acturers and Groshong catheters, which include a
alve and are used without heparin [14]. Catheters
re inserted in the unit or by other centres, and
aintained accordingly to the French consen-
us (http://www.srlf.org/Data/ModuleGestionDe
ontenu/PagesGenerees/Bibliotheque%20-%20
eferentiels/Referentiels/Recommandations/CC/
33.asp). The same, written procedure was avail-
ble locally during the entire period, concerning
nsertion, diagnosis of infection, maintenance or
ressing.
A questionnaire was completed for each
atheter. Infections were deﬁned, accordingly
o the French consensus (previously cited) as
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ollows: A case was classiﬁed as a catheter-related
nfection if the patient had purulent discharge at
he puncture, lymphangitis or positive quantitative
lood culture (number of bacteria/ml 5 times
r higher by puncture of catheter than by direct
uncture), thereby attesting a catheter-related
nfection, with or without catheter microbiological
xamination conﬁrming catheter colonisation.
atheter colonisation was deﬁned as a count of
ore than 100 colonies by plate using the semi
uantitative technique. A case was classiﬁed
s bacteraemia if the patient had one or more
ositive peripheral blood cultures, considered as
igniﬁcant (1 or more positive bottle for pathogenic
icroorganisms and 2 or more positive bottles for
aprophytes).
The clinical data were collected by the haema-
ologist physician, with the help of the nursing
eam, and microbiological data were collected by
he physician of the Hygiene and Epidemiology Unit
HEU) using microbiological laboratory software.
ll possible infections and positive samples were
iscussed. The data collected for each catheter
ere as follows: identity of the patient, date of
irth, sex, type of catheter, insertion and ablation
ates, ablation pattern, level of personal hygiene,
athology and, in the case of lymphoma, its type,
ate of diagnosis, number of lines of treatment,
ne or more autograft, episodes of infections
catheter-related infection or bacteraemia),
atheter colonisation and microorganisms. The
requency, the conditions and the type of use (only
erfusion or sample and perfusion) of catheter
ccess were not collected, because extra hospital
ata were not available. Each criterion was subject
o prior classical deﬁnition. The level of personal
ygiene was deﬁned according to the clean or
irty aspect of hands, clothes, hair, nails, at the
ime of inclusion. This scoring deﬁnition comes
rom a French network surveying catheter-related
nfection in dialysis (http://cclin-sudest.chu-
yon.fr/Reseaux/Dialin/Outil Dialin/2009/guide
ecueil2009.pdf). No speciﬁc ethical committee
ssessment was required for this observational
tudy. No speciﬁc grant was required for the
tudy. Data input and analysis were carried out
y the HEU, using SPSS V12. Univariate analysis
f potential risk factors was performed using the
antel-Haentzel 2 test for discrete variables and
he t test or an analysis of variance for continuous
ariables. Incidence rates were compared using a
test. The survival rate without catheter-related
nfection or bacteraemia was studied using a mul-
ivariate analysis using a Cox model incorporating
he duration of follow-up and other signiﬁcant risk
actors P < 0.20 in univariate analysis.
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Table 1 Pathology of patients.
Pathology Number of corresponding catheters Groshong Implantable port P*
N % N %
Lymphoma 241 72 29.9 169 70.1
Hodgkin 53 10 18.9 43 81.1
Myeloma 29 15 51.7 14 48.3
Chronic lymphocytic leukaemia 15 2 13.3 13 86.7
Thalassemia disease or assimilated 5 0 — 5 100 0.015
Acute lymphoblastic leukaemia 1 0 — 1 100
Others 9 1 11.1 8 88.9
Type of lymphoma
Diffuse B cell lymphoma 110 31 28.3 79 71.88
Follicular lymphoma 68 13 19.1 55 80.9
Mantle cell lymphoma 15 5 33.3 10 66.7 0.021
Angioimmunoblastic T-cell lymphoma 10 5 50.0 5 50.0
Peripheral T-cell lymphoma 6 3 50.0 3 50.0
c
i
f
D
o
o
t
s
t
t
n
r
i
b
p
w
B
n
(
i
b
r
a
a
s
i
t
A
i
o
TOthers 20
* Mantel-Haentzel 2 test.
Results
Three hundred and forty patients and 353 catheters
were included. Thirteen patients were observed for
2 successive catheters. One hundred and ninety ﬁve
catheters were ﬁtted on men and 158 on women.
The study included 253 implantable sites, followed
during a total of 51,049 days and 100 Groshong
catheters followed during a total of 17,621 days.
The mean duration of catheters before inclusion
was 202.5 days for implantable sites and 178.9 days
for Groshong catheters (P = 0.058).
Most of the patients had a lymphoma (241
catheters). The pathology of patients is presented
in Table 1. During the study, 31 bacteraemia were
noted (including 15 in connection with catheter and
16 of other origin) and 33 catheter-related infec-
tions. Catheter-related infections were 6 times
more frequently observed in patients with the
Groshong catheter, while the cumulative inci-
dence of bacteraemia was similar in both types
of catheters. Frequency of infections is presented
in Table 2. The duration of use of the catheter
being directly linked to the frequency of infec-
tions, the incidence of these infections per 100
days of follow-up allows a better comparison
between the different types of catheter for the
various clinical situations. This comparison (see
Table 2) shows that for 100 days of monitoring,
the frequency of infection was higher amongst
patients with the Groshong catheter: 0.13 catheter-
related infections and 0.07 bacteraemia were
observed, whereas 0.02 catheter-related infec-
tions and 0.04 bacteraemia were observed amongst
patients with an implantable port. Differences in
i
o
o
p6 33.3 14 66.7
atheter-related infections are statistically signif-
cant. Nevertheless, no signiﬁcant difference was
ound concerning catheter-related bacteraemia.
ue to the difference in incidence, an analysis
f risk factors was conducted separately by type
f catheter. For infections seen in patients with
he Groshong catheter (Table 3), the only factor
igniﬁcantly related to a greater risk of infec-
ion was lymphoma. When comparing the different
ypes of lymphomas, the difference was not sig-
iﬁcant, but the number of cases involved was
elatively few. No difference was found concern-
ng the mean duration of catheters before inclusion
etween infected and non infected catheters. For
atients with an implantable port, the lymphoma
as not associated with more frequent infection.
y contrast, treatment with erythropoietin was sig-
iﬁcantly associated with a higher infection rate
see Table 3). No difference was found concern-
ng the mean duration of catheters before inclusion
etween infected and non infected catheter. The
isk factors in this study are probably multiple
nd interrelated. They were included in a glob-
lly unique multivariate model to try to make the
tudy results as potent as possible and to take
nto account both the duration of monitoring and
he factors contributing to the onset of infection.
n analysis with a Cox model was produced by
ntroducing all potential factors (P < 0.20 in previ-
us univariate analysis). This analysis, presented in
able 4 and illustrated in Fig. 1, shows a signif-
cant independent effect of the type of catheter
n the incidence of catheter-related infection. No
ther factor was signiﬁcant (age, gender, level of
ersonal hygiene, pathology (see Fig. 1), number
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f lines of treatment, or treatment with erythro-
oietin, one or more autograft). Bacteraemia were
ore frequent with a high number of treatments,
ymphoma, treatment with erythropoietin and one
r more autograft. Type of catheter was not a
igniﬁcant factor for bacteraemia. No other fac-
or was signiﬁcant (age, gender, level of personal
ygiene). An analysis of the microorganisms identi-
ed shows a high frequency of Staphylococci, but
lso many other pathogens. For catheter-related
nfections, 18 gram positive microorganisms were
dentiﬁed (7 Staphyloccus aureus, methiciline resis-
ant in 2 cases, 5 Staphyloccus epidermidis and 6
thers Coagulase negative Staphylococci) and 13
ram negative microorganisms. For bacteraemia,
8 gram positive microorganisms (6 S. aureus,
ethiciline resistant in 4 cases, 7 S. epidermidis
nd 5 others Coagulase negative Staphylococci) and
3 gram negative microorganisms were identiﬁed.
iscussion
nfection was an uncommon event in this pop-
lation: patients having a Groshong catheter
resented about 2 infections per 1000 days of
ollow-up (2 out of 3 being catheter-related infec-
ions and 1 out of 3 bacteraemia), and patients
ith implantable sites less than 1 infection per 1000
ays (as many catheter-related infections as bac-
eraemia). Factors typically associated with most
requent infections were found, but all are not sta-
istically signiﬁcant, either for reasons of sample
ize or large numbers of missing values (level of
ygiene, for example).
But as each infection could be fatal to a haema-
ological patient, it is very important to aim for the
owest possible infection rate. To ensure this, the
ates found during the study were compared with
ublished data. The risk of infection with Groshong
atheters is similar to that with other long dura-
ion catheters, such as Hickman’s or Broviak’s [15].
he rates encountered in the study are compara-
le to those found in the literature for this type
f outpatient. In 2004 [8], the results published by
racchia et al. were comparable, showing an even
arger difference in infection rates between the two
ypes of catheters and infection rates comparable
o those observed in this study. Implantable ports
resented an infection-free survival rate of 97%
fter 1 year, similar to this study. A previous study
onducted at our hospital on implantable ports only
16], in 2000, measured 0.4 infections per 1000
ays in patients originating from all specialities
oncology, haematology, and patients affected with
138
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Table 3 Univariate analysis of risk factors on incidence of catheter infections and bacteraemia, by type of catheter.
Risk factors Groshong catheter Implantable ports
N days N Infections Incidence
per 100
days
Relative risk P* N days N Infections Incidence
per 100
days
Relative risk P*
Catheter infection
Male gender 8686 10 0.12 0.791 0.288 28362 5 0.02 0.799 0.362
Bad personal
hygiene
1382 2 0.14 1.119 0.439 4626 1 0.02 1.115 0.458
Lymphoma 12030 20 0.17 3.098 0.027 33218 5 0.02 5.369 0.158
Number of
treatments
(1/others)
12211 16 0.13 1.012 0.488 29265 7 0.02 1.736 0. 208
Autograft 5991 6 0.10 0.685 0.211 8651 0 0 0 0.077
Erythropoietin
treatment
6795 9 0.13 1.024 0.487 18999 6 0.03 2.530 0.068
Bacteraemia
Male gender 8686 8 0.09 2.057 0.114 28362 8 0.03 0.581 0.118
Bad personal
hygiene
1382 0 0.00 0 0.181 4626 1 0.02 0.557 0.282
Lymphoma 12030 11 0.09 5.112 0.041 33218 15 0.05 2.012 0.102
Number of
treatments
(1/others)
12211 10 0.08 2.215 0.145 29265 11 0.04 1.024 0.480
Autograft 5991 5 0.08 1.386 0.287 8651 4 0.05 1.306 0.317
Erythropoietin
treatment
6795 6 0.09 1.593 0.207 18999 15 0.08 6.326 <10(−4
* Z test.
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Table 4 Multivariate analysis of risk factors (Cox model) of catheter infections and bacteraemia, by patients with
Groshong catheter or implantable port.
Signiﬁcant factors Relative Risk CI de RR à 95% P
Catheter infections
Groshong versus implantable port 5.74 2.58—12.77 <10−3
Bacteraemia
Lymphoma versus other pathologies 3.19 1.05—9.68 0.041
Erythropoietin treatment (versus no) 2.88 1.31—3.36 0.009
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Number of treatments (numeral value) 0.
ystic ﬁbrosis). The microorganisms are very similar
o those observed in other studies in haematol-
gy [2,17]. These differences between implantable
orts and catheters are largely found in other
tudies [7,18], and are often also observed for bac-
eraemia in hospitalised patients [7].
These rates are lower than those reported
mongst hospitalised patients. For example, in
999, Albo Lopez et al. [6], observed 7.1 infec-
ions/1000 days with the Hickmann catheter,
ompared to 1.5 infections per 1000 days on
atheters with implantable ports. The difference
n infection risk is commonly used as an argument
gainst the use of Groshong catheters, but this dif-
erence seems limited to local infections. This point
nd the easier insertion and removal of Groshong
atheter should perhaps be taken into account in
hoosing the most suitable catheter.
What, then, are the high risk situations giving
ise to infection?
If global rates are similar to published rates,
erhaps it would be possible to detect differences
f
b
s
igure 1 Follow of catheter without infection curves, (Co
atheter type, B bacteraemia by lymphoma versus other diag1.33—8.48 0.011
0.46—0.99 0.047
n risk factors to identify new prevention targets.
he risk factors studied extensively in the litera-
ure are found partially here: The patient’s disease
s the ﬁrst example. Lymphomas were found to be
ore often associated with infections, in relation to
he specialty of the unit. Indeed, acute leukaemias
re usually more at risk [1,17] but these patients
re not widely supported in the ambulatory care
nit. Factors such as treatment with erythropoietin
r autograft [17] appear associated with a higher
isk of infection, probably because of their associ-
tion with higher levels of chemotherapy. The type
f chemotherapy was not recorded in this study,
lthough the choice of treatment is multi faceted,
f which infectious risk is only one consideration.
rythropoietin and growth factors have limited the
evel and duration of aplasia, which is classically a
igniﬁcant factor [2,19], but the beneﬁt of these
actors has largely now been realised and further
eneﬁt is not expected.
The level of a patient’s personal hygiene was the
ubject of an essay collection, but this factor could
x multivariate model): A catheter-related infection by
nosis.
R[
[
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not be considered because of large numbers of miss-
ing values. Training patients to use their catheter
well and have good personal hygiene is a major
concern for the unit [20], but it is impossible to ver-
ify that each patient has been correctly informed
about this, and properly respects the given instruc-
tions, especially when the catheters have not been
ﬁtted in the facility. Patient education is identi-
ﬁed as a possible target for better prevention, as
witnessed by its effective introduction in other hos-
pitals [20].
A major limitation of this study relates to
missing information: exact date of introduction,
information given to the patient concerning the
catheter, level of personal hygiene, the patient’s
ability to understand information, catheter use
and incidents outside the establishment. This point
limits possible pertinent comparisons, but ambula-
tory patients also require monitoring of infectious
events, adapted to their speciﬁc circumstances.
Classic surveillance did not appear to be the best
method of study for the ambulatory care unit,
because of the high workload associated with it.
Refocussing is planned on a method of analysis
based around ‘‘critical points’’ for speciﬁc cases of
reported infections, combined with improvement
in some aspects of care organisation. A detailed
review of the records of all infected patients iden-
tiﬁed during the surveillance was conducted to
identify additional risk elements (pathology, treat-
ment, reference of catheter, care and information).
It demonstrated an important failure concerning
traceability in medical records. A permanent single
point of monitoring questionnaire for catheters was
found to be useful, because of data which had hith-
erto been dispersed or missing. It was introduced
after this study.
At the end of this year of surveillance, it could
be conﬁrmed that, while infection rates were not
high enough to be a major concern, neither were
they so low as not to warrant attention. The
study and its review helped indicate possibilities
to enhance monitoring and prevention. Security
and hygiene information given at the beginning
of patient treatment should then be repeated,
and noted so in the records. Patient awareness
and training, currently only carried out at the
beginning of care should be repeated, with better
track records being kept. Simultaneously, a proce-
dure to investigate each infected patient has been
deﬁned to allow better follow-up of the quality of
care.
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